NR 567 Week 8 Final Exam Study Guide

  • NR 567 Week 8 Final Exam Study Guide
  • $25.00


Institution NR 567 Advanced Pharmacology for the Adult-Gerontology Acute Care Nurse
Contributor Jaime Bradely

Therapeutic dosing and monitoring of warfarin (Coumadin) & Types of anticoagulants- mechanisms of action and indications for use

 

Blood coagulation mechanisms:

  1. injury exposes subendothelial matrix proteins (i.e. collagen and von Willebrand factor) result in platelet adherence and activation, secretion and synthesis of vasoconstrictors and platelet-recruiting and activating molecules [thromboxane A2 is synthesized from acid within platelets; platelets secrete ADP (a platelet aggregator) and serotonin (stimulates aggregation and vasoconstriction)] = platelet plug
  2. Coagulation system cascade is activated resulting in thrombin generation and a fibrin clot, which stabilizes the platelet plug

*1 & 2 occur simultaneously.

Indirect Thrombin

Inhibitors

MOA

Dosage

Monitoring

Clinical Applications

Toxicities & Reversal

Unfractionated heparin (UFH, HMW)

1. Binds to antithrombin and inhibits clotting factor proteases thrombin, IXa, and Xa

Continuous IV infusion bolus: 80-100 units/kg followed by 15-22 units/kg per hour

Low dose prophylaxis: 5000 units subq Q8- 12h

Activated partial thromboplastin time (aPTT or PTT), CBC w/

platelet count

 

Bleeding, hair loss, HIT (heparin induced thrombocytopenia)

Long-term: osteoporosis, spontaneous fractures, mineralocorticoid deficiency

Protamine Sulfate: for every 100 units heparin remaining in patient, 1mg protamine sulfate given

IV

Low-Molecular-Weight Heparin Enoxaparin/Lovenox Dalteparin

Tinzaparin

1. Binds to antithrombin and inhibits clotting factor proteases thrombin

and Xa

Prophylactic: 30-40mg Q or BID

Full dose: 1mg/kg subq Q12h

 

Unnecessary

 

1mg protamine sulfate may partially neutralize 1 mg enoxaparin

Fondaparinux

1. binds antithrombin,

inhibiting factor Xa

Once daily, subq

Unnecessary

 

No reversal agent

 

Warfarin

MOA

Dosage

Monitoring

Clinical Applications

Toxicities & Reversal

Warfarin/Coumadin

1. blockade of

5-10mg, usually 5-

Prothrombin time

 

Teratogenic effects

 

 

 

gamma-carboxylation resulting in incomplete coagulation of factor molecules that are

inactive

7mg/d

Education: increased vitamin K intake (leafy greens) reduce anticoagulant effect

of warfarin

(PT) and INR INR gaal:2-3

INR goal w/ artificial heart valves: 2.5-3.5

 

PO/IV Vitamin K1, FFP, prothrombin complex concentrates (KCentra)

 

 

Instituition / Term
Term Year 2022
Institution NR 567 Advanced Pharmacology for the Adult-Gerontology Acute Care Nurse
Contributor Jaime Bradely
 

Related Products